With the legalization of medical and recreational cannabis in California and an increasing rate of acceptance and use, many physicians are already working with patients who use cannabis. Despite its popularity as one of the most commonly used drugs in the United States, physicians may be unprepared to discuss the benefits, risks, and side effects of cannabis. Join us for CAP's next webinar to learn the basics of medical cannabis, the dilemma it poses for unprepared physicians as patients seek their advice on treatment, and the inconsistencies between state and federal laws.
 

In our latest data study, CAP Risk Management staff evaluated 68 closed claims radiology cases that resulted in an indemnity payment between 2006 and 2015. Through claims analysis, we have identified areas to improve the medical diagnostic process. 

In a new opinion addressing allegations of elder abuse, the Court of Appeal explains how evidence of simple “negligence” differs from “recklessness” in a nursing facility setting.

Physicians are expected to uphold their ethical obligations toward the patient, and, in turn, the patient is expected to honor the suggestions and recommendations offered by the physician. What steps can the physician take to set these expectations, and what is the best course of action for the physician to follow in the case of the noncompliant patient?

The Department of Justice (DOJ) has certified California’s Controlled Substance Utilization Review and Evaluation System (CURES). Therefore, effective October 2, 2018, it will become mandatory for all healthcare practitioners who prescribe to consult and review the CURES 2.0 system prior to prescribing, ordering, administering, or furnishing a Schedule II-IV controlled substance.